A Randomized, Double-Blind, Multicenter Study to Evaluate the Acid-inhibitory and Dose-response Efficacy of TAK-438 (20 mg, 40 mg) in Patients With Proton Pump Inhibitor (PPI) - Resistant Erosive Esophagitis

PHASE3CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

July 31, 2012

Primary Completion Date

September 30, 2013

Study Completion Date

September 30, 2013

Conditions

Erosive Esophagitis

Interventions

DRUG

TAK-438

DRUG

TAK-438

Trial Locations (11)

Gifu

Sapporo

Hitachi-shi

Kochi

Sendai

Osaka

Saga

Izumo-shi

Hamamatsu

Bunkyo-ku

Mitaka-shi